Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05388097 · ClinicalTrials.gov registry record · NA

Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure

A NA study of Heart Failure, sponsored by Saint Luke's Health System.

Recruiting
Registry status
NA
Development phase
320
Enrollment target
3
Study locations

NCT05388097: Recruiting NA study of Heart Failure, sponsored by Saint Luke's Health System.

NCT05388097 is a NA study of Heart Failure that is actively recruiting participants, run by Saint Luke's Health System. The registered enrollment target is 320 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05388097, a NA study of Heart Failure, is actively recruiting participants, sponsored by Saint Luke's Health System.

RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
3
Study locations

Study Summary

The objective of this program is to improve post-acute care coordination for necessary social services for patients leaving the hospital after recovering from an episode of decompensated heart failure.

Conditions Studied

Interventions

  • OTHER Managed Services

Study Locations (3)

Missouri

  • University Health Truman Medical Center - Kansas City
  • Saint Luke's Hospital of Kansas City - Kansas City

Kansas

  • Olathe Health System - Olathe

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2021-05-03
Est. Completion 2026-06
Phase NA
Saint Luke's Health System

26 total trials

What NCT05388097 shows while recruiting

NCT05388097 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Managed Services is the first listed.

NCT05388097 reports a single indexed study location in Missouri, Kansas.

Frequently Asked Questions

What is clinical trial NCT05388097 about?

NCT05388097 is a clinical study titled "Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure". The objective of this program is to improve post-acute care coordination for necessary social services for patients leaving the hospital after recovering from an episode of decompensated heart failure.

What is the current status of trial NCT05388097?

This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2021-05-03. Estimated completion is 2026-06.

What conditions does trial NCT05388097 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT05388097?

The interventions under investigation include: Managed Services (OTHER).

Who is sponsoring clinical trial NCT05388097?

This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05388097 being conducted?

This trial has 3 study locations across Kansas, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05388097's enrollment target sits among peer trials

320 134th of 397 higher than 261 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02763683 · 320 participants

    Investigations of Dementia in Parkinson Disease

  • NCT03331198 · 320 participants · Phase 1

    Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

  • NCT03458832 · 320 participants

    Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

  • NCT03551951 · 320 participants

    Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05388097, the US trial registry maintained by the National Library of Medicine. NCT05388097 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.